UP to 400 Ranbaxy staff may
be affected by a widespread
retrenchment of executives at
senior and middle management
levels, according to India’s
Economic Times newspaper.
Executives from the Finance,
R&D and Active Pharma Ingredient
departments are reported to have
been handed pink slips last week
in the wake of Ranbaxy’s legal
troubles, which have seen the
company agree to pay half a billion
dollars to settle cases brought by
US authorities.
The US state of Idaho has
confirmed that it has received
about $420,000 as its part of the
settlement, addressing “losses
to the Idaho Medicaid program
caused by individuals and
companies,” according to an official
statement from Idaho Attorney
General Lawrence Wasden.The above article was sent to subscribers in Pharmacy Daily's issue from 10 Jul 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 10 Jul 13
NEW data from the Australian Institute of Health and Welfare has revealed around 43% (or 8.5 million) of Australians aged 16-85 have experienced a mental disorder at some point in their lives.
THE Pharmacy Guild of Australia has formally expressed its concerns regarding the potential merger between Sigma and Chemist Warehouse (PD 07 Dec 2023) to the Australian Competition and Consumer Commission (ACCC).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.